Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 7, Number 3—June 2001

Synopsis

Cryptococcus neoformans Infection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome

Shahid Husain, Marilyn M. Wagener, and Nina SinghComments to Author 
Author affiliations: Veterans Affairs Medical Center and University of Pittsburgh, Thomas E. Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA

Main Article

Table 2

Cerebrospinal fluid (CSF) characteristics in organ transplant recipients with central nervous system Cryptococcus neoformans infection

Variable (no. of patients for whom data available) Valuea
Opening pressure, mm H20 (17) 330 (140-700)
Leukocytes, mm3 (27) 33 (0-485)
Protein, mg/dL (27) 74 (16-715)
Glucose, mg/dL (27) 36 (4 - 113)
No. with positive India ink 80% (38/47)
No. with positive CSF cryptococcal antigen 100% (27/27)
Titer, median (range) 1:512 (1:4-1:32,768)
No. with positive CSF culture 93% (76/82)
No. with positive serum cryptococcal antigen Titer, median (range) 88% (14/16) 1:128 (1:4-1:4096)

aMedian and range unless otherwise stated.
bNumbers of patients for whom data were available.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO